MAIA · Company research

MAIA Biotechnology, Inc. (MAIA): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

19records availableHealthcare

Stock News & Events data

Database-backed records only

19 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Microsoft Stocks Slip Lower Although Maia Targets 40% More Tokens per Megawatt - TradingViewMicrosoft Stocks Slip Lower Although Maia Targets 40% More Tokens per Megawatt TradingViewView source ↗TradingViewOct 14, 2026neutral00.6
Why Nvidia Stock Is Up Even as Microsoft Launches the Maia 300 - Barron'sWhy Nvidia Stock Is Up Even as Microsoft Launches the Maia 300 Barron'sView source ↗Barron'sOct 13, 2026neutral00.6
How to Play Microsoft Stock Ahead of an Upcoming Maia 300 Launch - Yahoo FinanceHow to Play Microsoft Stock Ahead of an Upcoming Maia 300 Launch Yahoo FinanceView source ↗Yahoo FinanceOct 13, 2026neutral00.6
Microsoft Stock Forecast: Maia 300 Targets Azure Costs Ahead of October 28 Earnings - TradingKeyMicrosoft Stock Forecast: Maia 300 Targets Azure Costs Ahead of October 28 Earnings TradingKeyView source ↗TradingKeyOct 13, 2026neutral00.6
Microsoft Reveals Next-Gen Maia 300 Custom AI Chip For Widespread Deployment - Yahoo FinanceMicrosoft Reveals Next-Gen Maia 300 Custom AI Chip For Widespread Deployment Yahoo FinanceView source ↗Yahoo FinanceOct 13, 2026neutral00.6
Microsoft Unveils New Maia AI Chips on a Rough Day for Nvidia Stock - Barron'sMicrosoft Unveils New Maia AI Chips on a Rough Day for Nvidia Stock Barron'sView source ↗Barron'sOct 12, 2026neutral00.6
MAIA Biotechnology, Inc. SEC Filing (Oct 7, 2026) - Stock TitanMAIA Biotechnology, Inc. SEC Filing (Oct 7, 2026) Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
MAIA Biotechnology Releases New Investor Presentation and Update - The Globe and MailMAIA Biotechnology Releases New Investor Presentation and Update The Globe and MailView source ↗The Globe and MailOct 7, 2026neutral00.6
MAIA Biotechnology Announces Completion of THIO-101 Phase 2 Enrollment and Reaches 65% of THIO-104 Phase 3 Target - Quiver QuantitativeMAIA Biotechnology Announces Completion of THIO-101 Phase 2 Enrollment and Reaches 65% of THIO-104 Phase 3 Target Quiver QuantitativeView source ↗Quiver QuantitativeOct 7, 2026neutral00.6
150 people have received an experimental lung cancer drug in trials involving immunotherapy - Stock Titan150 people have received an experimental lung cancer drug in trials involving immunotherapy Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
A director's 38,871 options vest immediately at MAIA Biotechnology (MAIA), with a $1.18 exercise price. - Stock TitanA director's 38,871 options vest immediately at MAIA Biotechnology (MAIA), with a $1.18 exercise price. Stock TitanView source ↗Stock TitanOct 2, 2026neutral00.6
About 30,000 new lung cancer cases occur yearly in Spain and Portugal; a trial has approval to screen patients there. - Stock TitanAbout 30,000 new lung cancer cases occur yearly in Spain and Portugal; a trial has approval to screen patients there. Stock TitanView source ↗Stock TitanSep 23, 2026neutral00.6
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO - Yahoo FinanceMAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO Yahoo FinanceView source ↗Yahoo FinanceSep 15, 2026neutral00.6
Maia Biotechnology director Guerrero buys $2,386 in common stock - Investing.comMaia Biotechnology director Guerrero buys $2,386 in common stock Investing.comView source ↗Investing.comAug 26, 2026neutral00.6
Microsoft Stock Drops While Maia Chip Ambitions Expand - Yahoo FinanceMicrosoft Stock Drops While Maia Chip Ambitions Expand Yahoo FinanceView source ↗Yahoo FinanceAug 12, 2026neutral00.6
$MAIA ($MAIA) Releases Q2 2026 Earnings - Quiver Quantitative$MAIA ($MAIA) Releases Q2 2026 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeAug 10, 2026neutral00.6
Compugen: Better Runway Ahead Of MAIA - Seeking AlphaCompugen: Better Runway Ahead Of MAIA Seeking AlphaView source ↗Seeking AlphaAug 6, 2026neutral00.6
MAIA Forecast — Price Target — Prediction for 2027 - TradingViewMAIA Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 27, 2026neutral00.6
MAIA Biotechnology Executives Increase Stock Holdings, Express Confidence in Cancer Immunotherapy Development - Quiver QuantitativeMAIA Biotechnology Executives Increase Stock Holdings, Express Confidence in Cancer Immunotherapy Development Quiver QuantitativeView source ↗Quiver QuantitativeJun 2, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.